Trademark: 90336807
Status Date
Monday, February 19, 2024
Filing Date
Monday, November 23, 2020
Published for Opposition
Tuesday, November 23, 2021
Abandoned Date
Monday, February 19, 2024
5 Pharmaceuticals for the treatment of Acute Myeloid Leukemia; Pharmaceutical preparations for the treatment of Acute Myeloid Leukemia; Pharmaceutical products for the treatment of Acute Myeloid Leukemia
42 Pharmaceutical research and development
The English translation of GULZAR in the mark is Rose Garden.
"THERAPEUTICS"
Feb 20, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 19, 2024
Abandonment - No Use Statement Filed
Jul 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2023
Sou Extension 3 Granted
Jul 18, 2023
Sou Extension 3 Filed
Jul 18, 2023
Sou Teas Extension Received
Jan 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2023
Sou Extension 2 Granted
Jan 18, 2023
Sou Extension 2 Filed
Jan 18, 2023
Sou Teas Extension Received
Jul 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2022
Sou Extension 1 Granted
Jul 12, 2022
Sou Extension 1 Filed
Jul 12, 2022
Sou Teas Extension Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 18, 2021
Approved For Pub - Principal Register
Oct 15, 2021
Teas/Email Correspondence Entered
Oct 14, 2021
Correspondence Received In Law Office
Oct 14, 2021
Teas Response To Office Action Received
May 6, 2021
Notification Of Non-Final Action E-Mailed
May 6, 2021
Non-Final Action E-Mailed
May 6, 2021
Non-Final Action Written
May 6, 2021
Assigned To Examiner
Jan 28, 2021
New Application Office Supplied Data Entered
Nov 26, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
